Viewing Study NCT06138795


Ignite Creation Date: 2025-12-24 @ 2:11 PM
Ignite Modification Date: 2026-01-23 @ 3:00 PM
Study NCT ID: NCT06138795
Status: COMPLETED
Last Update Posted: 2025-09-09
First Post: 2023-11-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Single and Multiple Ascending Dose Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD2389 in Healthy Participants
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Participants View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Liver disease View
None Single ascending dose View
None Multiple ascending dose View